# Personalized Text Messages to Improve Antiretroviral Treatment (ART) Adherence in HIV+ Methamphetamine Users

> **NCT01317277** · NA · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 75 (actual)

## Conditions studied

- HIV
- AIDS

## Interventions

- **BEHAVIORAL:** individualized Texting for Adherence Building (iTAB)
- **BEHAVIORAL:** Psychoeducation

## Key facts

- **NCT ID:** NCT01317277
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2021-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01317277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01317277, "Personalized Text Messages to Improve Antiretroviral Treatment (ART) Adherence in HIV+ Methamphetamine Users". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01317277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*